BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26098110)

  • 1. Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin.
    Ekstrand M; Gustafsson Trajkovska M; Perman-Sundelin J; Fogelstrand P; Adiels M; Johansson M; Mattsson-Hultén L; Borén J; Levin M
    PLoS One; 2015; 10(6):e0130898. PubMed ID: 26098110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
    Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
    Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of methamphetamine promotes atherosclerosis formation in ApoE-/- knockout mice fed normal diet.
    Gao B; Li L; Zhu P; Zhang M; Hou L; Sun Y; Liu X; Peng X; Gu Y
    Atherosclerosis; 2015 Nov; 243(1):268-77. PubMed ID: 26409626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice.
    Jia F; Wu C; Chen Z; Lu G; Sun J
    Mol Med Rep; 2016 Apr; 13(4):3574-80. PubMed ID: 26956896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition.
    Tie C; Gao K; Zhang N; Zhang S; Shen J; Xie X; Wang JA
    PLoS One; 2015; 10(11):e0142430. PubMed ID: 26555472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
    Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
    Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical assessment of the quantification of atherosclerotic lesions in apoE⁻/⁻ mice.
    Lin Y; Bai L; Chen Y; Zhu N; Bai Y; Li Q; Zhao S; Fan J; Liu E
    Mol Med Rep; 2015 Oct; 12(4):5298-306. PubMed ID: 26239265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.
    Broisat A; Toczek J; Dumas LS; Ahmadi M; Bacot S; Perret P; Slimani L; Barone-Rochette G; Soubies A; Devoogdt N; Lahoutte T; Fagret D; Riou LM; Ghezzi C
    J Nucl Med; 2014 Oct; 55(10):1678-84. PubMed ID: 25157043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
    Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice.
    Xiao N; Yin M; Zhang L; Qu X; Du H; Sun X; Mao L; Ren G; Zhang C; Geng Y; An L; Pan J
    Mol Genet Metab; 2009 Apr; 96(4):239-44. PubMed ID: 19157944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-15 in mouse and human atherosclerotic lesions.
    Wuttge DM; Eriksson P; Sirsjö A; Hansson GK; Stemme S
    Am J Pathol; 2001 Aug; 159(2):417-23. PubMed ID: 11485899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition.
    Janssen H; Wagner CS; Demmer P; Callies S; Sölter G; Loghmani-khouzani H; Hu N; Schuett H; Tietge UJ; Warnecke G; Larmann J; Theilmeier G
    Dis Model Mech; 2015 Sep; 8(9):1071-80. PubMed ID: 26092124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin attenuates homocysteine-induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK.
    Bao XM; Zheng H
    Clin Exp Pharmacol Physiol; 2015 Aug; 42(8):865-73. PubMed ID: 26041506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.